Synmosa Biopharma Corporation, a specialty pharmaceutical company, engages in the manufacturing and sales of various pharmaceuticals and medical devices in Taiwan, China, the United States, Canada, Thailand, Malaysia, Singapore, and internationally. It offers medicines for urology, hormones, oncology, dermatology, cardiovascular, CNS, gastrointestinal, and other areas; and effervescent tables, granules, and nasal sprays. The company is also involved in provision of cosmetics, veterinary drugs, chemical food additives, and beverages; wholesale retail of environmental drugs; and import and export of related businesses. The company was founded in 1959 and is based in Taipei, Taiwan.
Frequently asked questions
What sector does Synmosa Biopharma (4114) operate in?
Synmosa Biopharma belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Synmosa Biopharma (4114) current stock price?
As of the latest data, Synmosa Biopharma stock price is NT$30.00, with a previous close of NT$29.80. Synmosa Biopharma gained NT$0.20 in the last trading session, representing a 0.67% increase.
What is Synmosa Biopharma (4114) current market capitalization?
Synmosa Biopharma market cap is approximately 16.33 billion.
What is Synmosa Biopharma (4114) Earnings Per Share (EPS)?
The trailing EPS is NT$1.49.
What is Synmosa Biopharma (4114) Price-to-Earnings (P/E) ratio?
Synmosa Biopharma current P/E ratio is 20.13.
Does Synmosa Biopharma (4114) pay dividends?
Yes. Synmosa Biopharma pays annual dividends with an annualized yield of 2.83% and an estimated annual payout of NT$0.85 per share.
When is the next ex-dividend date for Synmosa Biopharma (4114)?
The next ex-dividend date is scheduled for July 17, 2027.
What is Synmosa Biopharma (4114) beta (volatility) score?
Synmosa Biopharma has a beta of -0.027, indicating lower volatility than the overall market.
